Introduction
The outbreak of coronavirus disease 2019 (COVID-19) has received much attention due to its multi-systemic effects, including COVID-19-related neurologic features. Recent evidence highlights a relatively high percentage (36%) of central nervous system symptoms, including headache, altered mental status, acute cerebrovascular disease, and epilepsy, in patients with COVID-191,2. Due to immunosuppression, pregnant women are considered to be at high risk for COVID-19 infection. A case of acute hemorrhagic encephalitis(AHE) in a pregnant woman was reported in Mardin State Hospital, Diyarbakir, Turkey.
Case report
A 32-year-old pregnant woman with a 12-day history of fever and cough was admitted to the emergency department for confusion and severe headache at 24 weeks of gestation. The patient experienced hypoxic respiratory failure, which worsened into severe acute respiratory distress syndrome, necessitating intubation and mechanical ventilation while the patient was heavily sedated. She reported deterioration for 5 days with headache, confusion, and dyspnea. A polymerase chain reaction test from the nasopharyngeal swab confirmed the diagnosis of coronavirus disease (COVID-19). A computed tomography (CT) scan of the chest was also suggestive of COVID-19. Neurological examination showed dysarthria and mild hemihypoesthesia. The unenhanced axial and reformatted coronal thorax computed tomography (CT) images show peribronchovascular and subpleural ground-glass opacities and vascular dilatation in the bilateral lung, which was also highly suggestive of COVID-19. Magnetic resonance imaging (MRI) of the brain showed bilateral periventricular, thalamic, parahippocampal, and mesencephalic lesions with hyperintensity in axial fluid-attenuated inversion recovery (FLAİR) and T2WI, internal hemorrhage that caused susceptibility changes in susceptible-weighted imaging (SWI) images. The baby was delivered by cesarean section.
Discussion
Preterm births are more prevalent in pregnant mothers with COVID-19. An uncommon and frequently fatal neurological side effect of COVID-19 is AHE3,4. Findings of MRI are suggestive of underlying AHE2. In differential diagnoses of patients presenting with neurological symptoms who have COVID-19, AHE should be considered. High clinical suspicion and early imaging diagnosis of this condition can enable clinicians to pursue more aggressive treatment options to reduce fatal outcomes4,5.
References
Comprising seasoned professionals and experts from the medical field, the IJCP editorial team is dedicated to delivering timely and accurate content and thriving to provide attention-grabbing information for the readers. What sets them apart are their diverse expertise, spanning academia, research, and clinical practice, and their dedication to upholding the highest standards of quality and integrity. With a wealth of experience and a commitment to excellence, the IJCP editorial team strives to provide valuable perspectives, the latest trends, and in-depth analyses across various medical domains, all in a way that keeps you interested and engaged.
Please login to comment on this article